NCT02824263View on ClinicalTrials.gov

Metabolic Impact of Intermittent CPAP

NACompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

July 10, 2016

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
Obstructive Sleep Apnea
Interventions
OTHER

CPAP withdrawal

CPAP is discontinued for 3 nights.

Trial Locations (1)

21224

Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

American Academy of Sleep Medicine

OTHER

lead

Johns Hopkins University

OTHER

NCT02824263 - Metabolic Impact of Intermittent CPAP | Biotech Hunter | Biotech Hunter